IL154666A0 - 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds - Google Patents

17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds

Info

Publication number
IL154666A0
IL154666A0 IL15466601A IL15466601A IL154666A0 IL 154666 A0 IL154666 A0 IL 154666A0 IL 15466601 A IL15466601 A IL 15466601A IL 15466601 A IL15466601 A IL 15466601A IL 154666 A0 IL154666 A0 IL 154666A0
Authority
IL
Israel
Prior art keywords
compounds
production
pharmaceutical compositions
compositions containing
methylene steroids
Prior art date
Application number
IL15466601A
Other languages
English (en)
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of IL154666A0 publication Critical patent/IL154666A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15466601A 2000-09-04 2001-08-29 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds IL154666A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10043846A DE10043846A1 (de) 2000-09-04 2000-09-04 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen
PCT/EP2001/009943 WO2002019971A1 (de) 2000-09-04 2001-08-29 4-halogenierte 17-methylensteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
IL154666A0 true IL154666A0 (en) 2003-09-17

Family

ID=7655148

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15466601A IL154666A0 (en) 2000-09-04 2001-08-29 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
IL154666A IL154666A (en) 2000-09-04 2003-02-27 71-Methylene steroids, method of manufacture and pharmaceuticals containing these compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154666A IL154666A (en) 2000-09-04 2003-02-27 71-Methylene steroids, method of manufacture and pharmaceuticals containing these compounds

Country Status (29)

Country Link
EP (1) EP1423407B1 (et)
JP (1) JP2004513084A (et)
KR (1) KR100530816B1 (et)
CN (1) CN1262560C (et)
AT (1) ATE319733T1 (et)
AU (2) AU2002210470B2 (et)
BG (1) BG107594A (et)
BR (1) BR0113618A (et)
CA (1) CA2421302C (et)
DE (2) DE10043846A1 (et)
DK (1) DK1423407T3 (et)
EA (1) EA006387B1 (et)
EE (1) EE05186B1 (et)
ES (1) ES2260294T3 (et)
HK (1) HK1060135A1 (et)
HR (1) HRP20030256A2 (et)
HU (1) HUP0300936A3 (et)
IL (2) IL154666A0 (et)
ME (1) MEP14408A (et)
MX (1) MXPA03001912A (et)
NO (1) NO325012B1 (et)
NZ (1) NZ524485A (et)
PL (1) PL360669A1 (et)
PT (1) PT1423407E (et)
RS (1) RS50305B (et)
SK (1) SK286757B6 (et)
UA (1) UA74592C2 (et)
WO (1) WO2002019971A1 (et)
ZA (1) ZA200301715B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141984A1 (de) * 2001-08-28 2003-03-20 Jenapharm Gmbh Neue 17-Methylen-4-azasteroide
US7199115B2 (en) 2004-04-19 2007-04-03 Schering Ag 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611773A (en) * 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US3146239A (en) * 1957-09-23 1964-08-25 Syntex Corp 4-halo-19-nor-progesterone
US3232960A (en) * 1959-10-08 1966-02-01 Upjohn Co 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
US4389345A (en) * 1981-10-09 1983-06-21 G.D. Searle & Co. 3-Oxoestra-17-acetonitrile and unsaturated analogs
US5994334A (en) * 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
WO2002000681A1 (en) * 2000-06-27 2002-01-03 Aventis Pharma S.A. 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase

Also Published As

Publication number Publication date
WO2002019971A1 (de) 2002-03-14
SK2442003A3 (en) 2003-08-05
DE50109175D1 (de) 2006-05-04
SK286757B6 (sk) 2009-05-07
ZA200301715B (en) 2004-08-13
CN1452628A (zh) 2003-10-29
NO325012B1 (no) 2008-01-14
PL360669A1 (en) 2004-09-20
WO2002019971A9 (de) 2002-08-08
HUP0300936A2 (hu) 2003-11-28
MEP14408A (en) 2010-06-10
EE05186B1 (et) 2009-06-15
HUP0300936A3 (en) 2010-01-28
BR0113618A (pt) 2003-07-15
RS50305B (sr) 2009-09-08
MXPA03001912A (es) 2004-07-08
EA200300322A1 (ru) 2003-10-30
CA2421302A1 (en) 2003-03-03
PT1423407E (pt) 2006-07-31
DK1423407T3 (da) 2006-07-03
UA74592C2 (en) 2006-01-16
IL154666A (en) 2008-12-29
KR100530816B1 (ko) 2005-11-25
DE10043846A1 (de) 2002-04-04
YU16403A (sh) 2006-05-25
EA006387B1 (ru) 2005-12-29
EE200300087A (et) 2005-02-15
HRP20030256A2 (en) 2005-10-31
CA2421302C (en) 2007-08-14
NO20030989L (no) 2003-05-02
EP1423407A1 (de) 2004-06-02
BG107594A (bg) 2003-09-30
AU2002210470B2 (en) 2006-07-20
KR20030028836A (ko) 2003-04-10
AU1047002A (en) 2002-03-22
NZ524485A (en) 2005-11-25
NO20030989D0 (no) 2003-03-03
ATE319733T1 (de) 2006-03-15
EP1423407B1 (de) 2006-03-08
JP2004513084A (ja) 2004-04-30
ES2260294T3 (es) 2006-11-01
HK1060135A1 (en) 2004-07-30
CN1262560C (zh) 2006-07-05

Similar Documents

Publication Publication Date Title
HUP0102483A2 (hu) Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
HK1054332A1 (zh) 具有全身效應的新型局部雌激素孕激素組合物
WO2002058706A3 (en) Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
ATE293979T1 (de) Pharmazeutische zusammensetzungen enthaltend syntethisch natürliche progesteron und estradiol und verfahren zur herstellung derselben
DE60115274D1 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
IL125821A0 (en) A pharmaceutical composition containing dehydroepiandrosterone and aromatase inhibitors and use thereof
SG154323A1 (en) Estrogen replacement therapy
IL154666A0 (en) 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
MXPA05008347A (es) Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis.
WO2002020000A3 (en) Combined estrogen blockade of the breast with exemestane and raloxifene
Whitehead Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data
UA85190C2 (en) PROCESS FOR THE SYNTHESIS OF PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS AND THE MIXTURE OF ISOMERS, AND USE OF THOSE ISOMERS
WO2003103614A3 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF OEDEMATUS FIBROSCLEREUS PANNICULOPATHY
AR048829A1 (es) 17alfa - fluoroesteroides con actividad inhibidora de 5 alfa-reductasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades cancerosas influidas por androgenos.
DE59907558D1 (de) Mittel zur stabilisierung von lebensmitteln und kosmetischen mitteln sowie verfahren zu dessen herstellung
WO2003045971A3 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
BR0016092A (pt) Composto, uso de um composto kit para contracepção hormonal em um macho, e, método de tratamento